MedImmune To Release Phase III Data By Year-End For Synagis Follow-On
This article was originally published in The Pink Sheet Daily
Executive Summary
MedImmune is on track to launch the newest member of its respiratory syncytial virus therapy franchise for the 2008–2009 respiratory virus season.